Ildong Holdings Co., Ltd.

KSE 000230.KS

Ildong Holdings Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2023: 8.35

Ildong Holdings Co., Ltd. Debt to Equity Ratio is 8.35 for the year ending December 31, 2023, a -68.99% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Ildong Holdings Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2022 was 26.93, a 343.11% change year over year.
  • Ildong Holdings Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2021 was 6.08, a 205.47% change year over year.
  • Ildong Holdings Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2020 was 1.99, a 16.37% change year over year.
  • Ildong Holdings Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2019 was 1.71, a 315.54% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Loading...
KSE: 000230.KS

Ildong Holdings Co., Ltd.

CEO Dae-Chang Park
IPO Date Jan. 4, 2000
Location South Korea
Headquarters 2, Baumoe-ro 27-gil
Employees 78
Sector Health Care
Industries
Description

Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer's disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It also engages in the research and manufacture of health foods and ingredients, as well as offers hyaluronic acid for use in drugs, medical devices, and cosmetics; and various medical devices for beauty, cosmetic-surgery, and antiaging applications. In addition, the company distributes medical devices, quasi drugs, health supplements, food products, beverages, cosmetics, sanitary ware, and other healthcare products through online. Further, it offers beauty and cosmetic surgery services; and pharmaceutical SI consulting, system development and deployment, RFID and barcode systems, and other solutions, as well as engages in advertising business. The company was formerly known as Ildong Pharmaceutical Co., Ltd. and changed its name to Ildong Holdings Co., Ltd. in August 2016. Ildong Holdings Co., Ltd. was founded in 1941 and is based in Seoul, South Korea.

Similar companies

000640.KS

Dong-A Socio Holdings Co., Ltd.

USD 68.20

0.14%

000100.KS

Yuhan Corporation

USD 89.21

-4.31%

000140.KS

Hitejinro Holdings Co., Ltd.

USD 6.11

0.63%

000020.KS

Dongwha Pharm.Co.,Ltd

USD 4.37

0.43%

000520.KS

Samil Pharmaceutical Co.,Ltd

USD 9.49

2.21%

StockViz Staff

January 15, 2025

Any question? Send us an email